MetLife Investment Management’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $644K | Hold |
25,874
| – | – | ﹤0.01% | 1560 |
|
|
2025
Q1 | $802K | Sell |
25,874
-410
| -2% | -$12.7K | ﹤0.01% | 1469 |
|
|
2024
Q4 | $829K | Buy |
26,284
+1,173
| +5% | +$37K | ﹤0.01% | 1514 |
|
|
2024
Q3 | $1.45M | Sell |
25,111
-453
| -2% | -$26.2K | 0.01% | 1182 |
|
|
2024
Q2 | $1.04M | Buy |
25,564
+2,958
| +13% | +$120K | 0.01% | 1328 |
|
|
2024
Q1 | $949K | Hold |
22,606
| – | – | 0.01% | 1326 |
|
|
2023
Q4 | $866K | Hold |
22,606
| – | – | 0.01% | 1380 |
|
|
2023
Q3 | $697K | Hold |
22,606
| – | – | 0.01% | 1428 |
|
|
2023
Q2 | $714K | Buy |
22,606
+2,395
| +12% | +$75.7K | 0.01% | 1466 |
|
|
2023
Q1 | $737K | Hold |
20,211
| – | – | 0.01% | 1404 |
|
|
2022
Q4 | $598K | Hold |
20,211
| – | – | ﹤0.01% | 1523 |
|
|
2022
Q3 | $788K | Hold |
20,211
| – | – | 0.01% | 1316 |
|
|
2022
Q2 | $780K | Hold |
20,211
| – | – | 0.01% | 1352 |
|
|
2022
Q1 | $980K | Buy |
20,211
+7,056
| +54% | +$342K | 0.01% | 1340 |
|
|
2021
Q4 | $967K | Hold |
13,155
| – | – | 0.01% | 1142 |
|
|
2021
Q3 | $1.2M | Hold |
13,155
| – | – | 0.01% | 1043 |
|
|
2021
Q2 | $826K | Buy |
13,155
+3,742
| +40% | +$235K | 0.01% | 1281 |
|
|
2021
Q1 | $255K | Hold |
9,413
| – | – | ﹤0.01% | 1916 |
|
|
2020
Q4 | $172K | Hold |
9,413
| – | – | ﹤0.01% | 2058 |
|
|
2020
Q3 | $169K | Buy |
+9,413
| New | +$169K | ﹤0.01% | 1955 |
|
|
2019
Q4 | – | Sell |
-12,990
| Closed | -$229K | – | 2331 |
|
|
2019
Q3 | $229K | Buy |
+12,990
| New | +$229K | ﹤0.01% | 1872 |
|